Transacting transcriptional activation of human spumaretrovirus LTR in infected cells by Rethwilm, Axel et al.
VIROLOGY 175, 568-571 (1990) 
Transacting Transcriptional Activation of Human Spumaretrovirus LTR in lnfected Cells 
AxEL RETHWILM, 1 KAZUYASU MORI, BERND MAURER, AND VOLKER TERMEULEN 
Institut für Virologie, Universität Würzburg, Versbacher Strasse 7, 8700 Würzburg, Federal Republic of Germany 
Received August 25, 1989; accepted December 11, 7989 
The long terminal repeat (LTR) of the human spumaretrovirus (HSRV) was examined with respect to its ability to 
function as transcriptional promotor in virus-infected and uninfected cells. Transient transfections using a plasmid in 
which the 3' L TR of HSRV was coupled to the bacterial chloramphenicol acetyltransferase (cat) gene revealed that the 
Ievei of HSRV LTR-directed cat gene expression was markedly increased in HSRV-infected cells compared to unin-
fected cells. Northern blot analysis of cat mRNA from transfected cultures suggests that transactivation of HSRV-
directed gene expression occurs at the transcriptionallevel. © 1990 Academic Prass,lnc. 
Spumaretroviruses, which are also called foamy vi-
ruses, are a distinct group of retroviruses ( 1}, ubiqui-
tous in nonhuman primates, bovines, and felines (2}. 
They induce persistent infections in their hosts without 
apparent clinical disease (2). Isolation of human foamy 
viruses have been reported from primary cultures of tis-
sues of various human diseases (3-6) and a low sero-
posivity has been found in populations of East Africa 
and pacific islands {7, 8). However, so far any defined 
disease has not been associated with this group of vi-
ruses (9). 
The recent reports on the molecular biological char-
acterization of a human isolate obtained in 1971 from 
nasopharyngeal carcinoma cells (6) has again raised 
interest in this agent since its genomic organization 
shows similarities to the other human retroviruses ( 1, 
9). lt has been found that the HSRV genome carries the 
information for at least four gene products in addition 
to the gag, pol, and env genes characteristic for all ret-
roviruses. Three of these, called bel 1, 2, and 3 are lo-
cated between the env gene and the 3' L TR. The fourth 
additional open reading frame (ORF), S 1, is located be-
tween the pol and the env gene ( 10, 11). Since there is 
a limited but significant homology between the bel 1 
ORF of HSRV and the human immunodeficiency virus 
(HIV) type 2 tat gene, a similar function of these genes 
has been suggested (12). To assess this hypothesis 
we investigated the activity of L TR-directed transcrip-
tion in virus-infected and uninfected cells. 
Parent plasmid for the L TR cat constructs was the 
cat expression plasmid pSV2cat (13). Deletion of a 
50 1-base pair (bp) Ace II Hindill fragment containing the 
SV40 regulatory sequences and insertion of Hindill or 
Bg/lllinkers led to plasmids pOcat-H and pOcat-Bg, re-
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spectively. The construct pHSRVcat was derived from 
the viral DNA clone pHSRV-852, which harbors the se-
quences from nucleotide position 91 03 in the bel 1 
ORF to the 3' end of the viral genome (10). Plasmid 
pHSRV-852 was cut with Saul at nucleotide position 
+316 (start of transcription is + 1) in the U5 region of 
the 3' L TR, as deduced from cap site mapping ( 11}, and 
Bg/lllinkers were inserted leading to pHSRV-852-Bg. A 
1488-bp Bg/11 fragment .of pHSRV-852-Bg, running 
from a Bg/11 site at nucleotide position 9788 in the bei 
2 ORF to the newly created Bg/11 site, was cloned in 
sense orientation 5'to the cat gene of pOcat-Bg. Thus, 
pHSRVcat contains 262 bp of flanking viral sequences 
prior to the start of the LTR (Fig. 1 ). For comparative 
purposes control plasmids pSV2cat, known to function 
in a wide variety of cell types {73), and pCMVcat were 
included in transfection experiments. Plasmid pCMV-
cat was constructed by inserting a 815-bp Hindlll-
linked Ba/1/Sphl fragment from pRR23 containing the 
human cytomegalovirus immediate early gene en-
hancer/promotor (14) into pOcat-H. As shown in Fig. 1 
pCMVcat harbors hCMV sequences from nucleotide 
positions -670 to + 145. 
HSRV was grown on baby hamster kidney cells 
(BHK-21) and on human glioblastoma cellline U-251 
MG as described ( 15). Twenty micrograms of DNA was 
transfected into 5 x 1 05 cells in a petri dish (80 mm) as 
a calcium phosphate coprecipitate (16). For transfec-
tion of HSRV-infected cells 2 ml cell-free supernatant 
from a HSRV-infected culture was added to the freshly 
seeded cells 1 day prior to transfection. After adding 
the DNA precipitate cells were incubated overnight at 
37° followed by a glycerol shock and change of me-
dium ( 17). Cells were harvested 48 hr after transfection 
and processed as described {13). CAT assays were 
performed with 50 1-'9 of protein as determined using a 
commercial protein assay (Bio-Rad), 0.1 #-'Ci [14C]chlor-
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FIG. 1. Plasmids used for transfections. Construct pHSRVcat harbors a 1488-bp Bg/11 fragment 5' to the cat gene of pOcat-Bg, comprising 
262 bp of flanking viral sequences {v.f.}, U3, R, and U5 regions to nucleotide position +309 of the 3' LTR. Plasmid pCMVcat harbors the 
immediate early gene enhancer/promotor region of hCMV 5' to the cat gene of pOcat-H. Molecular cloningwas performed according to estab-
lished methods (28}, and plasmid constructions were confirmed by extensive restriction enzyme digestions. Enzymes were used as specified 
by the manufacturer {BRL and Boehringer-Mannheim}. BamHI (8}, Bg/11 (Bg), EcoRI (E}, Hindill (H), Pstl (P). 
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FIG. 2. Timecourse of the CAT activity in extracts prepared from BHK-21 cells (a} and HSRV-infected BHK-21 cells (b). Cultures were trans-
fected with pHSRVcat (0), pCMVcat (e), and pSV2cat (0). The mean of three experiments is shown. 
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TABLE 1 
COMPILATIONOF CAT ÄSSAYS UStNG LYSATES FROM HSRV-INFECTED 
AND UNINFECTED BHK-21 AND U-251 MG CELLS 
pSV2cat 
39.7 
1.0 
79.3 
1.0 
n.d. 
n.d. 
pCMVcat 
40.9 
1.03 
pHSRVcat 
BHK-21 
0.7 
0.02 
BHK-21 HSRV infected 
95.6 
1.2 
n.d. 
57.7 
0.73 
U-251 MG 
0.4 
U-251 MG HSRV infected 
n.d. 17.0 
% conversion 
relative to pSV2cat 
% conversion 
relative to pSV2cat 
% conversion 
% conversion 
Note. The percentage of acetylated chloramphenicol from total in-
put chloramphenicol and the percentage of acetylation relative to 
that obtained with control plasmid pSV2cat are shown. Ten micro-
grams of protein were run in a 1-hr reaction, and the mean value from 
three experimentswas determined. n.d., not done. 
amphenicol (Amersham), and 3 J.LM acetyi-CoA (Sigma) 
in a 1 00-J.LI reaction volume. At various time points ali-
quots of 20 J.LI were taken and extracted with ethyl·ace-
tate. Acetylated and unacetylated chloramphenicol 
were separated by ascending thin layer chromatogra-
phy, and chromatography plates were exposed to X-
ray films overnight. Acetylated chloramphenicol was 
calculated from total input chloramphenicol by cutting 
out the spots from the chromatography plate and liquid 
scintillation counting. All values were determined from 
three independent transfections and CAT assays. 
As shown in Fig. 2a the HSRV L TR-driven cat gene 
is nonfunctional when transfected into uninfected 
BHK-21 cells. CAT activities in lysates prepared from 
pSV2cat and pCMVcat transfected cells increase lin-
early with incubation time, indicating efficient uptake 
and expression of DNA. ln contrast, a high Ievei of CAT 
activity was found upon transfection of pHSRVcat into 
HSRV-infected BHK-21 cells (Fig. 2b}, indicating that 
like HIV and HTLV { 18, 19) HSRV encodes for a transac-
tivator capable of enhancing transcription from its own 
L TR. Levels of CAT activities using the control plas-
mids were found to be about twofold higher in infected 
cells compared to uninfected cells (Fig. 2b, Table 1 ). lt 
has been reported recently th.at retroviral transactiva-
tors may stimulate heterologous viral promotors, such 
as the SV40 promotor (20, 21). Whether this mecha-
nism accounts for the observed effect remains to be 
elucidated. On the other hand, uninfected and infected 
cells may differ in the uptake of foreign DNA by the 
transfection procedure used. We therefore expressed 
CAT Ievels relative to those of pSV2cat as summarized 
in Table 1. Bythis calculation gene expression directed 
by the HSRV LTR was enhanced by a factor of 36.5 in 
HSRV-infected BHK-21 cells as compared to unin-
fected cells. Stimulation was found to be in the same 
range using the U-251 MG cellline. 
Different mechanisms of transactivator-mediated 
Stimulation of retroviral transcription have been sug-
gested especiallyfor HIV (22-24). Since several reports 
indicated a regulation at least in part at the post-tran-
FIG. 3. Northern blot hybridization ·of cat mRNA from pHSRVcat-
transfected cultures. Two micrograms of poly(A)+ RNA from BHK-21 
(a) and 1 1-'9 from HSRV-infected BHK-21 cells (b) were separated on 
a denaturating agarase gel and blotted onto a nylon membrane. The 
filterwas hybridized overnight with a cat-specific probe in 50% for-
mamide, 100 "'g/ml t-RNA, 5X SSC, 0.02 M sodium pyrophosphate. 
5X Denhardt's solution, and 1% SOS at 42°, washed three times for 
30 min in 2X SSC, 0.1% SOS at 68°, and exposed to Cronex X-ray 
film (DuPont). The probe was washed off the filter as specified by the 
manufacturer, and the filterwas rehybridized with a ß-actin probe 
under the same conditions. Probes were labelad according to Fein-
berg and Vogelstein (33) to a specific activity of 5 x 108 cpm/"'g. 
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scriptional Ievei (25, 26}, we investigated whether 
HSRV LTR-directed cat mRNA could be detected in un-
infected and HSRV-infected cells. Petri dishes with un-
infected and HSRV-infected BHK-21 cells (a number of 
six each) were transfected with pHSRVcat. Forty-eight 
hours later cells from one petri dish were used to pre-
pare cellular extracts for CAT assay and RNA from the 
cultures transfected in parallel was extracted by the 
guanidinium-isothyocyanate method (27). Poly(A)+ 
RNA was selected on oligo(dT) cellulose (28}, sepa-
rated on a formaldehyde-containing agarase gel and 
blotted onto GeneScreen plus membranes (DuPont). 
Filters were hybridized with an internal 250-bp EcoRI/ 
Hindill fragment from the cat gene and were rehybrid-
ized with a ß-actin probe (29). As shown in Fig. 3 no cat 
mRNA could be detected in uninfected BHK-21 cells 
transfected with pHSRVcat (lane a}, while in HSRV-in-
fected cells cat mRNA approximately 1.8 kb in size was 
clearly detected with a cat-specific probe (lane b). CAT 
assays from cultures transfected in parallel showed 
0.4% conversion of chloramphenicol in uninfected and 
64.6% conversion of chloramphenicol in HSRV-in-
fected cells, respectively. Thus, Ieveis of cat mRNA in 
Northern blot and Ieveis of CAT protein in CAT assay 
correlate weil in this experiment. This result suggests 
that transactivation of HSRV L TR-directed gene ex-
pression occurs mainly at the transcriptional Ievei. 
However, further experiments are needed to elucidate 
the mechanism by which HSRV transactivates its own 
LTR more precisely. As a first step to identify the HSRV 
gene responsible for transactivation we have con-
structed an infectious molecular clone for HSRV (A. Re-
thwilm et al., manuscript in preparation). Deletion mu-
tants of this clone as weil as of the HSRV L TR in the 
HSRVcat plasmid should allow the investigation of the 
specific transactivation mechanism of HSRV. 
The pathogenic human retroviruses of the lentiviral 
and oncoviral group both encode for transactivators. 
Evidence has been presented that the viral proteins re-
sponsible for transactivation may alter the expression 
of cellular genesandas in the case of HTLVI TAX pro-
tein may be directly involved in viral pathogenicity (30-
32). The presence of a transactivator in HSRV-infected 
cells should therefore reinforce studies on the molecu-
lar biology and epidemiology of HSRV. This view is 
strengthened if one takes into account that the overall 
genome structure of HSRV closely resembles those of 
HIV and HTLV (1). 
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